Christopher Kong, Glasgow Royal Infirmary British Society of Gastroenterology Annual Meeting. Birmingham, March 20-23, 2006 A combination of a drug and an photophoresis machine has been used in an att
Christopher Kong, Glasgow Royal InfirmaryBritish Society of Gastroenterology Annual Meeting. Birmingham, March 20-23, 2006A combination of a drug and an photophoresis machine has been used in an attempt to inactivate white cells among patients with Crohn’s disease. The experimental treatment uses the combined action of methoxypsoralen and ultra-violet light to produce a biological effect which could benefit patients whose Crohn’s disease is refractory to other forms of treatment. At the British Society of Gastroenterology Annual Meeting held in Birmingham Christopher Kong presented early data from a group of five patients receiving what is called photoimmune therapy.
Related Episodes
Jonathan Wesley Riess MD; 2026 AACR: Investigational KRAS(ON) Inhibitor Zoldonrasib Showed Effective and Durable Responses in Patients With Advanced G12D-mutated Lung Cancer
Investigational KRAS(ON) Inhibitor Zoldonrasib Showed Effective and Durable Responses in Patients With Advanced G12D-mutated Lung Cancer An interview with: Jonathan Wesley Riess MD, Professor of Medic
Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone
Cora Sternberg REFERENCE: Abstract 4010, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 CORA STERNBERG, San Camillo and Forlanini Hospital, Rome Satraplatin could pro
Live Report from ASH:<br />Oblimersen Extends Survival in Chronic Lymphocytic Leukemia
Susan O’Brien SUSAN O’BRIEN, MD Anderson Cancer Center, Houston For patients with relapsed or refractory CLL, oblimersen extends survival when added to standard fludarabine/cyclophosphamid